Home » Authors » James Etheridge

James Etheridge

Articles

ARTICLES

Neurotech Acquires Exclusive License From Amgen For CNTF

Jan. 16, 2002

By James Etheridge

Neurotech Acquires Exclusive License From Amgen For CNTF

Jan. 16, 2002

By James Etheridge

French Parliament Could Vote To Allow Therapeutic Cloning

Jan. 16, 2002

By James Etheridge

ExonHit Partners With IDEC To Develop Antibody Therapeutics

Jan. 9, 2002

By James Etheridge

PARIS - ExonHit Therapeutics SA and IDEC Pharmaceuticals Corp. signed a collaboration and research agreement aimed at discovering new antigen targets for antibody therapy, with a particular focus on prostate carcinoma.

ExonHit Partners With IDEC To Develop Antibody Therapeutics

Jan. 9, 2002

By James Etheridge

PARIS - ExonHit Therapeutics SA and IDEC Pharmaceuticals Corp. signed a collaboration and research agreement aimed at discovering new antigen targets for antibody therapy, with a particular focus on prostate carcinoma.

Crucell Unveils AdVac, Its New Genetic Vaccination Technology

June 6, 2001

By James Etheridge

Crucell Unveils AdVac, Its New Genetic Vaccination Technology

June 6, 2001

By James Etheridge

Transgene Financing Nets $54M; BioMérieux Stake Reaches 70%

May 30, 2001

By James Etheridge

Hybrigenics, Institut Curie Create Joint Cancer Research Facility

May 30, 2001

By James Etheridge

Neurotech Raises $30M Privately To Fund Work In Cell Therapies

May 30, 2001

By James Etheridge

View All Articles by James Etheridge

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...